BENZACLIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Benzaclin, and when can generic versions of Benzaclin launch?
Benzaclin is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in BENZACLIN is benzoyl peroxide; clindamycin phosphate. There are seventeen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the benzoyl peroxide; clindamycin phosphate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BENZACLIN?
- What are the global sales for BENZACLIN?
- What is Average Wholesale Price for BENZACLIN?
Summary for BENZACLIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 78 |
| Clinical Trials: | 4 |
| Drug Prices: | Drug price information for BENZACLIN |
| What excipients (inactive ingredients) are in BENZACLIN? | BENZACLIN excipients list |
| DailyMed Link: | BENZACLIN at DailyMed |
Recent Clinical Trials for BENZACLIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Glenmark Pharmaceuticals Ltd. India | Phase 3 |
| Taro Pharmaceuticals USA | Phase 1 |
| Loreal USA | N/A |
Pharmacology for BENZACLIN
| Drug Class | Lincosamide Antibacterial |
| Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
US Patents and Regulatory Information for BENZACLIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch | BENZACLIN | benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 050756-001 | Dec 21, 2000 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bausch | BENZACLIN | benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 050756-002 | Apr 20, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
